NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

NCT05262556 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Gastroenteropancreatic Neuroendocrine Tumor
Gastroenteropancreatic Neuroendocrine Neoplasm
Neuroendocrine Carcinoma
Mixed Neuroendocrine-Non Neuroendocrine Neoplasm

Interventions

DRUG: NP-101 (TQ Formula)
DRUG: Nivolumab (3mg/kg)
DRUG: Ipilimumab (1mg/kg)

Sponsor

Amr Mohamed MD

Collaborators

[object Object]